Table II. Primary Outcomes.
This table depicts objectively measured adherence and asthma knowledge at baseline, week 5 and week 10 of the active treatment phase. There was 8% missing data at weeks 5 and 10.
| Adherence to ICS % Adherence | ZAP Asthma Knowledge Instrument % Items Correct | |||||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
| ||||||||||
| Evaluation | Treatment | Control | P value | Treatment | Control | P value | ||||
| N | Median (Q1, Q3) | N | Median (Q1, Q3) | N | Median (Q1, Q3) | N | Median (Q1, Q3) | |||
| Baseline | 34 | 27.4 (14.3, 35.0) | 34 | 25.9 (14.0, 37.5) | 0.670 | 34 | 67.9 (59.0, 76.9) | 34 | 70.5 (61.5, 76.9) | 0.825 |
| 5 Weeks | 24 | 18.8 (5.4, 24.2) | 22 | 16.1 (7.14, 19.6) | 0.534 | 29 | 74.4 (59.0, 84.6) | 28 | 73.1 (56.4, 79.4) | 0.655 |
| 10 Weeks | 24 | 7.1 (0.9, 21.4) | 25 | 14.3 (5.4, 21.4) | 0.929 | 29 | 71.8 (59.0, 82.1) | 29 | 69.2 (61.5, 74.4) | 0.487 |